Clinical details | MOH + CMa patients | EMb patients | Healthy controls | p value |
---|---|---|---|---|
Age, years | 46.6 ± 10.3 | 38.0 ± 14.4 | 40.8 ± 9.7 | 0.078 |
Sex | 3Mc, 14Fd | 4Â M, 14Â F | 11Â M, 19Â F | 0.298 |
Headache history, years | 22.8 ± 8.9 | 10.8 ± 6.9 |  N/Ae | < 0.001 |
Medication-overuse duration, years | 7.3 ± 6.4 |  N/A | N/A | N/A |
Headache location | ||||
Right; Left; Bilateral | 2 (11.8 %); 2 (11.8 %); 13 (76.5 %) | 2 (11.1 %); 7 (38.9 %); 9 (50 %) | N/A; N/A; N/A | N/A; N/A; N/A |
VASf | 8.4 ± 1.4 | 8.0 ± 1.4 |  N/A | 0.465 |
PHQ9 | 8.7 ± 6.7 | 2.4 ± 4.8 | 2.5 ± 2.2 | < 0.05h |
GAD-7i | 2.9 ± 3.9 | 1.6 ± 3.6 | 2.6 ± 2.1 | 0.729 |